Holdings of Versant Venture Management, LLC
6 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 6 | 133.9M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics Inc | 3,180,780 | 52.3M $ | |
| 2 | Century Therapeutics Inc | 12,166,109 | 27.5M $ | |
| 3 | LENZ Therapeutics Inc | 2,656,888 | 24.3M $ | |
| 4 | JADE BIOSCIENCES INC | 1,525,820 | 21.4M $ | |
| 5 | Contineum Therapeutics Inc | 542,628 | 7.1M $ | |
| 6 | SKYE BIOSCIENCE INC | 2,007,704 | 1.2M $ |